Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,205.1
16.6 (0.52%)

 

  • STI Straits Times Index
    3,205.1
    16.6 (0.52%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,588.1
    -3.5 (-0.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,126.9
    109.4 (0.42%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,582.6
    -12.2 (-0.34%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,804.8
    96.3 (0.34%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,643.7
    10.8 (0.16%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,256.9M
  • Value: 811.0M
  • Rise: 183
  • Fall: 150
  • Unch: 418

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.068-0.003
King Wan0.055-0.002
Boldtek0.084+0.020
Sembcorp Marine0.079-0.001
Sinjia Land0.086+0.007
Raffles Edu0.071+0.010
Rex Intl0.345-0.005
ThaiBev0.715+0.010
Shen Yao0.002-0.001
No Signboard0.052-

World Indices

World Indices
Name Last Change
Nasdaq 15,090.2 -125.5
HSI 26,126.9 +109.4
HSCEI 9,356.9 +83.3
Jakarta 6,643.7 +10.8
Nikkei 225 28,804.8 +96.3
SSE Comp 3,582.6 -12.2
Shanghai A 3,754.7 -12.7
Shanghai B 275.7 -1.8
KOSPI 3,006.2 -1.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Kimia Farma Tbk. KIMIA FARMA
Quotes 10 Minutes Delayed. Updated at 22 Oct 2021 15:14
Last (IDR): 2,410.000 Change: -10.000 High: 2,430.000 Remarks: -
Change (%): -0.41 Low: 2,380.000
Open 2,430.000 Yesterday's Close 2420.000
Buy Price 2400.000 Sell Price 2410.000
Buy Volume ('000) 163.1 Sell Volume ('000) 0.9
Cumulative Volume ('000) 1,321.5 Cumulative Value 3,173,520,000
Click to show Stock Prices chart

Key Statistics

EPS (IDR) a 3.17588 Trailing EPS (IDR) e 4.80088 NAV (IDR) b 1,264.4516
PE a 758.845 Trailing PE f 501.992 Price / NAV b 1.9060
Dividend (IDR) d 1.270351 Cash In Hand (IDR) g 112.4070 Issued & Paid-up Shares c 5,554,000,000
Dividend Yield (%) d 0.053 Price / Cash In Hand g 21.440 Treasury Shares h -
Beta - 75 Daysi 0.738 R-Squared - 75 Days(%)i 6.15 Market Cap (M) 13,385,140.002
Beta - 500 Daysi 1.503 R-Squared - 500 Days (%)i 11.52 Enterprise Value (M) 20,878,379.963
Piotroski F Score 6 Exchange Code KAEF Par Value ( IDR ) 100.00000
52 Weeks Volatility (%) 69.42 6-Month VWAP 3000.529 Free Float (%) 10.0
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 16 Jul 2015.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 16 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Kimia Farma Tbk. IDX 13,385,140.002 758.845 501.992 1.9060 0.053
Industry Pharmaceuticals: Major IDX 5,601,056.751 72.240 50.320 2.1073 1.699
Local Peer Soho Global Health Tbk. IDX 6,472,767.000 37.609 28.419 2.9586 4.627
Local Peer Merck Tbk. IDX 1,563,520.000 21.745 12.887 2.2522 3.496
Local Peer Phapros Tbk. IDX 982,800.000 20.269 14.145 1.3522 1.973
Global Peer JOHNSON & JOHNSON NYSE 430,989.626 29.291 24.105 - 2.431
Global Peer PFIZER INC NYSE 241,984.740 25.165 18.293 3.4548 3.520
Global Peer ELI LILLY AND COMPANY NYSE 233,166.619 37.646 38.409 36.1813 1.214
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 206,730.946 25.611 23.011 3.8254 2.270
Global Peer MERCK & CO INC NYSE 205,420.676 29.068 36.873 6.1699 3.055
Global Peer ABBVIE INC NYSE 192,870.025 42.333 29.272 15.3448 4.430
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 191,442.103 59.901 50.767 12.2124 1.879
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 187,909.086 29.161 26.395 17.9730 1.269
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 127,993.536 - - 3.4773 3.226
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 126,144.845 8.986 18.216 1.6821 2.712
Other Global Peers GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), WUXI APPTEC CO LTD (HKEx), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), ROYALTY PHARMA PLC (NASDAQ), VIATRIS INC (NASDAQ), REPLIGEN CORP (NASDAQ), HANSOH PHARMACEUTICAL GROUP CO LTD (HKEx), INNOVENT BIOLOGICS INC (HKEx), CANSINO BIOLOGICS INC (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), ORGANON & CO (NYSE), SINOPHARM GROUP CO. LTD. (HKEx), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), CUREVAC NV (NASDAQ), REMEGEN CO LTD (HKEx), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), ALLAKOS INC (NASDAQ), HYGEIA HEALTHCARE HLDGS CO LTD (HKEx), HUTCHMED (CHINA) LIMITED (HKEx), HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS (NASDAQ), SHANGHAI PHARMACEUTICALS HOLDING CO (HKEx), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), AKESO INC (HKEx), SHANGHAI JUNSHI BIOSCIENCES CO LTD (HKEx), CHINA MEDICAL SYSTEM HLDGS LTD (HKEx), GUANGZHOU BAIYUNSHAN PHARMACEUTICAL (HKEx), KARUNA THERAPEUTICS INC (NASDAQ), INNOCARE PHARMA LTD (HKEx), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), REATA PHARMACEUTICALS INC (NASDAQ), IMMUNITYBIO INC (NASDAQ), CHINA RESOURCES PHARMACEUTICAL GR (HKEx), CARSGEN THERAPEUTICS HLDGS LTD (HKEx), NEKTAR THERAPEUTICS (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), CHINA GRAND PHARMACEUTICAL & HEALTH (HKEx), APELLIS PHARMACEUTICALS INC (NASDAQ), SIMCERE PHARMACEUTICAL GRP LTD (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), OPKO HEALTH INC (NASDAQ), CHINA TRADITIONAL CHINESE MED HLDGS (HKEx), ATAI LIFE SCIENCES NV (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), ERASCA INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), ADC THERAPEUTICS SA (NYSE), QUANTERIX CORPORATION (NASDAQ), EVEREST MEDICINES LTD (HKEx), SHANGHAI HENLIUS BIOTECH INC (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), IGM BIOSCIENCES INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), SHENZHEN HEPALINK PHARMACEUTICAL (HKEx), SSY GROUP LIMITED (HKEx), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), CSTONE PHARMACEUTICALS (HKEx), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), OCUMENSION THERAPEUTICS (HKEx), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), UNITED LABORATORIES INTL HLDGS LTD (HKEx), GENERATION BIO CO (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), PROCAPS GROUP S A (NASDAQ), BEIJING TONG REN TANG CHINESE MEDIC (HKEx), OLEMA PHARMACEUTICALS INC (NASDAQ), IMMUNOTECH BIOPHARM LTD (HKEx), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), ZYMEWORKS INC (NYSE), ATEA PHARMACEUTICALS INC (NASDAQ), ABBISKO CAYMAN LTD (HKEx), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), ICOSAVAX INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), SCICLONE PHARMACEUTICALS (HLDGS) LT (HKEx), FULCRUM THERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), KRONOS BIO INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), CK LIFE SCIENCES INTL HLDG (HKEx), TENAYA THERAPEUTICS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), ANTENGENE CORP LTD (HKEx), MIND MEDICINE (MINDMED) INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), PETIQ INC (NASDAQ), ANNEXON INC (NASDAQ), GH RESEARCH PLC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), CHINA SHINEWAY PHARMACEUTICAL GR (HKEx), POINT BIOPHARMA GLOBAL INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), VERU INC (NASDAQ), TRANSCENTA HOLDING LTD (HKEx), BEYONDSPRING INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), GRITSTONE BIO INC (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), HUA MEDICINE (HKEx), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), PHARVARIS NV (NASDAQ), ZHAOKE OPHTHALMOLOGY LTD (HKEx), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVOLUS INC (NASDAQ), AC IMMUNE SA (NASDAQ), IGBB (Bursa), PYXIS ONCOLOGY INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), MINK THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), PROVENTION BIO INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), CLENE INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), 89BIO INC (NASDAQ), RACE ONCOLOGY LTD (ASX), EYEPOINT PHARMACEUTICALS INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), CLEARSIDE BIOMEDICAL INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), DAWNRAYS PHARMACEUTICAL HLDGS (HKEx), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), TOT BIOPHARM INTL CO LTD (HKEx), CODIAK BIOSCIENCES INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), BIOMEA FUSION INC (NASDAQ), CYBIN INC (NYSE American), FUSION PHARMACEUTICALS INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), BSTEAD (Bursa), NEXIMMUNE INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), ATHENEX INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), DURECT CORP (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), FUSEN PHARMACEUTICAL CO LTD (HKEx), TCR2 THERAPEUTICS INC (NASDAQ), PHARMA (Bursa), ANGION BIOMEDICA CORP (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), VINCERX PHARMA INC (NASDAQ), ANNOVIS BIO INC (NYSE American), GAMIDA CELL LTD (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), IMMUNIC INC (NASDAQ), OBSEVA SA (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), TRICIDA INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), MUSTANG BIO INC (NASDAQ), IP (SET), PHASEBIO PHARMACEUTICALS INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), ALZAMEND NEURO INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), EYENOVIA INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), CHINA BIOTECH SERVICES HLDGS LTD (HKEx), HOOKIPA PHARMA INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), POLYPID LTD (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), NOVAN INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), IX Biopharma (SGX), AYALA PHARMACEUTICALS INC (NASDAQ), ZHONGZHI PHARMACEUTICAL HLDGS LTD (HKEx), LOGICBIO THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), RECCE PHARMACEUTICALS LTD (ASX), ODONATE THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), NOXOPHARM LTD (ASX), LANTERN PHARMA INC (NASDAQ), GENPREX INC (NASDAQ), LANNETT CO INC (NYSE), KOTRA (Bursa), DARE BIOSCIENCE INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), CRESO PHARMA LTD (ASX), YUMANITY THERAPEUTICS INC (NASDAQ), CHARMACY PHARMACEUTICAL CO LTD (HKEx), IMARA INC (NASDAQ), NEW RAY MEDICINE INTL HLDG LTD (HKEx), CLARUS THERAPEUTICS HLDGS INC (NASDAQ), PROPHASE LABS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), GALECTO INC (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MANNATECH INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), NOVA (Bursa), AYTU BIOPHARMA INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), PAK FAH YEOW INTERNATIONAL (HKEx), NEW CENTURY HEALTHCARE HLDGS CO LTD (HKEx), Hyphens Pharma (SGX), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), EXOPHARM LTD (ASX), ABVC BIOPHARMA INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), BIOHLDG (Bursa), SANAI HEALTH INDUSTRY GP CO LTD (HKEx), INVION LTD (ASX), WAI YUEN TONG MEDICINE HOLDINGS LTD (HKEx), MODERN CHINESE MEDICINE GRP CO LTD (HKEx), SHENZHEN NEPTUNUS INTERLONG BIO-TEC (HKEx), UNIVERSE PHARMACEUTICALS INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), RENOVORX INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), BONE BIOLOGICS CORP (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), BAUDAX BIO INC (NASDAQ), PURAPHARM CORPORATION LIMITED (HKEx), MEDLAB CLINICAL LIMITED (ASX), SEQLL INC (NASDAQ), PALLA PHARMA LTD (ASX), ARIDIS PHARMACEUTICAL INC (NASDAQ), PHARMAXIS (ASX), CNS PHARMACEUTICALS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), XORTX THERAPEUTICS INC (NASDAQ), DERMATA THERAPEUTICS INC (NASDAQ), PASITHEA THERAPEUTICS CORP (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), AGEX THERAPEUTICS INC (NYSE American), ACER THERAPEUTICS INC (NASDAQ), EXTRAWELL PHARMACEUTICAL HLDGS (HKEx), JCT (SET), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), SUNZEN (Bursa), ONCOSIL MEDICAL LIMITED (ASX), NLS PHARMACEUTICS LTD (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), TIMBER PHARMACEUTICALS INC (NYSE American), ACRUX (ASX), PAINREFORM LTD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), IMMURON LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TALI DIGITAL LIMITED (ASX), ISLAND PHARMACEUTICALS LTD (ASX), NANJING SINOLIFE UNITED COMPANY LTD (HKEx), PETROS PHARMACEUTICALS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), SUDA PHARMACEUTICALS LTD (ASX), CHINA SXT PHARMACEUTICALS INC (NASDAQ), PA SHUN INTERNATIONAL HOLDINGS LTD (HKEx), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --200.000
-7.66 %
10 Days --160.000
-6.23 %
20 Days -+70.000
+2.99 %
Medium Term Return 3 Months --590.000
-19.67 %
6 Months 1.270-350.000
-12.64 %
1 Year 1.270-810.000
-25.12 %
Long Term Return 2 Years 1.270-390.000
-13.88 %
3 Years 16.250-70.000
-2.17 %
5 Years 43.540+270.000
+14.65 %
Annualised Return Annualised --
+2.77 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 2,190.000 - 7,575.000 Change From 1 Year Low +220.000 % Change From 1 Year Low (%) +10.05
Change From 1 Year High -5165.000 % Change From 1 Year High (%) -68.18
2 Years Range 540.000 - 7,575.000 Change From 2 Years Low +1870.000 % Change From 2 Years Low (%) +346.30
Change From 2 Years High -5165.000 % Change From 2 Years High (%) -68.18
5 Years Range 540.000 - 7,575.000 Change From 5 Years Low +1870.000 % Change From 5 Years Low (%) +346.30
Change From 5 Years High -5165.000 % Change From 5 Years High (%) -68.18
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

PT Kimia Farma Tbk engages in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company was founded on January 23, 1969 and is headquartered in Jakarta, Indonesia.

Historical Price Data

Date Open High Low Close Volume VWAP
22 Oct 2021 2430.000 2430.000 2380.000 2410.000 1,321,500 2401.4529
21 Oct 2021 2500.000 2500.000 2410.000 2420.000 2,765,600 2439.9573
19 Oct 2021 2570.000 2600.000 2420.000 2440.000 8,333,700 2490.8101
18 Oct 2021 2610.000 2630.000 2570.000 2570.000 4,145,300 2586.5829
15 Oct 2021 2630.000 2710.000 2610.000 2610.000 7,307,300 2657.3518
14 Oct 2021 2680.000 2710.000 2580.000 2640.000 6,257,500 2630.7749
13 Oct 2021 2600.000 2690.000 2600.000 2680.000 7,648,200 2646.3251
12 Oct 2021 2560.000 2590.000 2550.000 2590.000 2,882,300 2574.2646
11 Oct 2021 2570.000 2600.000 2540.000 2560.000 2,813,700 2567.8974
08 Oct 2021 2680.000 2730.000 2540.000 2570.000 13,212,900 2624.6207
07 Oct 2021 2480.000 2660.000 2470.000 2640.000 17,293,600 2581.5072
06 Oct 2021 2430.000 2500.000 2420.000 2470.000 6,072,600 2449.8875
05 Oct 2021 2410.000 2480.000 2370.000 2430.000 4,495,200 2431.7917
04 Oct 2021 2370.000 2420.000 2360.000 2400.000 2,945,500 2388.9027
01 Oct 2021 2400.000 2430.000 2360.000 2360.000 1,693,400 2386.5460
30 Sep 2021 2460.000 2540.000 2380.000 2400.000 8,460,600 2463.6112
29 Sep 2021 2340.000 2460.000 2310.000 2420.000 5,140,300 2404.6740
28 Sep 2021 2350.000 2370.000 2340.000 2350.000 1,426,000 2357.6487
27 Sep 2021 2340.000 2360.000 2340.000 2350.000 628,700 2345.7993
24 Sep 2021 2330.000 2350.000 2330.000 2340.000 798,000 2340.0464
23 Sep 2021 2360.000 2380.000 2320.000 2340.000 936,400 2349.5451
22 Sep 2021 2400.000 2410.000 2360.000 2360.000 1,014,900 2377.9318
Summary
Current 2 Weeks
(08 Oct 2021 to 22 Oct 2021)
2680.000 2730.000 2380.000 2410.000 56,688,000 -
Previous 2 Weeks
(24 Sep 2021 to 07 Oct 2021)
2330.000 2730.000 2330.000 2640.000 48,953,900 -
4 Weeks from
(27 Aug 2021 to 23 Sep 2021)
2380.000 2730.000 2350.000 2340.000 26,265,900 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.